DOCSLIB.ORG

What Is in This Leaflet 1. What Flurbiprofen Coated Tablets Are

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
What Is in This Leaflet 1. What Flurbiprofen Coated Tablets Are What is in this leaflet 1. What Flurbiprofen Coated Tablets are and Package Leaflet: what they are used for Information for the Patient 2. What you need to know before you take Flurbiprofen Coated Tablets Flurbiprofen 50 mg 3. How to take Flurbiprofen Coated Tablets Coated Tablets 4. Possible side effects Flurbiprofen 100 mg 5. How to store Flurbiprofen Coated Tablets Coated Tablets 6. Contents of the pack and other information 1. What Flurbiprofen Coated Tablets are Flurbiprofen and what they are used for Flurbiprofen Coated Tablets belong to a group of medicines called non-steroidal anti- inflammatory drugs (NSAIDs). They can be used to relieve pain and inflammation (redness, heat and swelling) in conditions such as: IMPORTANT INFORMATION • osteoarthritis (a bone disorder, which is seen mostly in older persons, in which the joints Read all of this leaflet carefully become painful and stiff) before you start taking this medicine • rheumatoid disease (inflammation of the because it contains important joints and sometimes surrounding tissues) information for you. • ankylosing spondylitis (arthritis of the spine) • swollen joints, frozen shoulder, bursitis • Keep this leaflet. You may need to (inflammation of the bursa), tendinitis read it again. (inflammation of tendons), tenosynovitis • If you have any further questions, (inflammation of the covering layer of a ask your doctor or pharmacist. tendon) • This medicine has been prescribed • low back pain, sprains and strains. for you only. Do not pass it on to others. It may harm them even if Flurbiprofen Coated Tablets can also be their signs of illness are the same used to treat other painful conditions such as as yours. toothache, pain after operations, period pain • If you get any side effects, talk to and migraine. your doctor or pharmacist. This The active substance in Flurbiprofen Coated includes any possible side effects Tablets is flurbiprofen. Flurbiprofen 50 mg not listed in this leaflet. See section 4. Coated Tablets contains 50 mg of flurbiprofen and Flurbiprofen 100mg Coated Tablets contains 100 mg of flurbiprofen. 2. What you need to know before you take Flurbiprofen Coated Tablets Do not take Flurbiprofen Coated Tablets: • If you are sensitive (allergic) to any of the ingredients in the tablets. These are listed in Section 6. Ingredients known to cause allergic reactions are also listed at the end of this section. • If you have, or have had a peptic ulcer (ulcer in your stomach or duodenum), ulcerative colitis, Crohn’s disease or bleeding in your stomach, or have had two or more episodes of peptic ulcers, stomach bleeding or perforation in the past. • If you suffer from asthma or you have ever had an allergic reaction or suffered from wheezing after taking flurbiprofen, ibuprofen, aspirin or other anti-inflammatory pain killers. 1 PAGE 1 / FRONT 1 Description Flurbiprofen_50mg_100mg_100 Date: 01 Mar 19 Time: 19:30 Component Type Leaflet Pharma Code TBC No. of colours 1 Page Count 1/4 Affiliate Item Code 1761901 SAP No. N/A Colours Black Superceded Affiliate Item Code 1635100 Vendor Job No. 101962166/0020 Non-Print Keyline Technical TrackWise PR No. 1761901 Trackwise Proof No. 1 Colours Info MA No. PL 46302/ 0013-0012 Client Market United Kingdom Equate CMYK Packing Site/Printer Famar (L Aigle - FR) Keyline/Drawing No. ALLC0081-ZT with Supplier Code TBC Barcode Info N/A Main Font Helvetica Neue LT Pro Body Text Size 9.2 pt 3D Render ID N/A Dimensions 160 x 240 mm Min Text Size used 9.2 pt Sign-offs v3/Jul 2017 • If you are in the last trimester (last 3 months) are used to treat high blood pressure of pregnancy. • Anti-coagulants (to prevent blood clots e.g. • If you have been told by your doctor that warfarin) you have severe heart failure, liver failure or • Lithium kidney failure. • Zidovudine (an anti-viral drug) • If you currently have acute dehydration. • Methotrexate (used to treat certain cancers) Warnings and precautions • Ciclosporin and tacrolimus (immunosup- Talk to your doctor or pharmacist before pressants used to dampen down your taking Flurbiprofen Coated Tablets immune response) • Medicines known as corticosteroids • If you are pregnant or planning to become (used in the treatment of inflammatory pregnant, or you are breastfeeding diseases e.g. prednisone, dexamethasone, Flurbiprofen Coated Tablets may make it hydrocortisone) more difficult to become pregnant. You • Anti-depressant medication known as should inform your doctor if you are planning selective serotonin reuptake inhibitors to become pregnant or if you have problems (SSRls) (e.g. fluoxetine and paroxetine) becoming pregnant. • Antibiotics called quinolones (such as • If you have systemic lupus erythematosus ciprofloxacin) (SLE, sometimes known as lupus) or a • Mifepristone (now or in the last 12 days) connective tissue disease (autoimmune • Any other anti-inflammatory pain killers, diseases affecting connective tissue). including aspirin and the group of drugs • If you suffer from liver or kidney disease or known as COX-2 inhibitors e.g. celecoxib, have you ever been told you have liver or lumiracoxib. kidney disease. Pregnancy, breast-feeding and fertility • If you suffer from heart problems or have you ever been told you have heart problems. The use of Flurbiprofen Coated Tablets whilst Medicines such as Flurbiprofen Coated pregnant or breast-feeding should be avoided. Tablets may be associated with a small Flurbiprofen Coated Tablets should not be increased risk of heart attack (myocardial used in late (the last three months) pregnancy. infarction) or stroke. Any risk is more likely If you are pregnant or breast-feeding, think with high doses and prolonged treatment. you may be pregnant or are planning to have a Do not exceed the recommended dose baby, ask your doctor or pharmacist for advice or duration of treatment. If you have heart before taking this medicine. problems, previous stroke or think that you Driving and using machines might be at risk of these conditions (e.g. if Flurbiprofen Coated Tablets may make you you have high blood pressure, diabetes, feel dizzy, drowsy or tired and/or you may have high cholesterol or are a smoker) you should problems with your sight. If the tablets affect discuss your treatment with your doctor or you in this way do not drive, operate machinery pharmacist. or do anything that requires you to be alert. • If you have you been diagnosed as having a condition that affects the time it takes your Flurbiprofen Coated Tablets contain glucose, blood to clot sucrose and lactose • If you have been told by your doctor that you If you have been told by your doctor that have an intolerance to some sugars. Please you have an intolerance to some sugars you see “Flurbiprofen Coated Tablets contain should check with your doctor before taking glucose, sucrose and lactose” at the end Flurbiprofen Coated Tablets. of this section. Other information about Flurbiprofen Coated Other medicines and Flurbiprofen Coated Tablets: Tablets Your doctor may give you another medicine to Tell your doctor or pharmacist if you are taking, be taken with Flurbiprofen Coated Tablets to have recently taken or might take any other help protect your stomach, if they think you are medicines. In particular, tell your doctor or at risk of getting a stomach ulcer or bleeding in pharmacist if you are taking and of the following your stomach. medicines: If you take a painkiller for headaches for a • Diuretics (known as water tablets e.g. prolonged length of time, it can make them furosemide, spironolactone) worse. • Cardiac glycosides (medicines used for Avoid alcohol intake while taking Flurbiprofen heart conditions, such as digoxin) Coated Tablets, since this may increase the risk • ACE inhibitors (e.g. captopril) or Angiotensin of some side-effects listed in Section 4 . II antagonists (e.g. losartan). These medicines 2 PAGE 2 / BACK 1 Description Flurbiprofen_50mg_100mg_100 Date: 01 Mar 19 Time: 19:30 Component Type Leaflet Pharma Code TBC No. of colours 1 Page Count 2/4 Affiliate Item Code 1761901 SAP No. N/A Colours Black Superceded Affiliate Item Code 1635100 Vendor Job No. 101962166/0020 Non-Print Keyline Technical TrackWise PR No. 1761901 Trackwise Proof No. 1 Colours Info MA No. PL 46302/ 0013-0012 Client Market United Kingdom Equate CMYK Packing Site/Printer Famar (L Aigle - FR) Keyline/Drawing No. ALLC0081-ZT with Supplier Code TBC Barcode Info N/A Main Font Helvetica Neue LT Pro Body Text Size 9.2 pt 3D Render ID N/A Dimensions 160 x 240 mm Min Text Size used 9.2 pt Sign-offs v3/Jul 2017 3. How to take Flurbiprofen Coated • Severe skin reactions such as blistering of the Tablets skin, mouth, eyes and genitals (symptoms of some severe skin conditions that may occur Always take this medicine exactly as your rarely with Flurbiprofen Coated Tablets). doctor has told you. Check with your doctor or pharmacist if you are not sure. Tell your doctor IMMEDIATELY and stop taking the tablets if you experience: Take your Flurbiprofen Coated • Unexplained stomach pain or other abnormal Tablets with or after food with a stomach symptoms, indigestion, heartburn, glass of water. feeling sick and/or vomiting. The recommended dose is: • Increased bruising or bleeding, fever, Adult -The usual daily dose is 150 to 200 mg, sore throat, mouth ulcers, tiredness and spread throughout the day. If you are taking a tendency to get infections (symptoms of Flurbiprofen 50 mg Coated Tablets this will blood disorders that may occur rarely with be three or four times a day. If you are taking Flurbiprofen Coated Tablets). Flurbiprofen 100 mg Coated Tablets this will be • Yellowing of the eyes and/or skin. This is a sign one or two tablets a day. Sometimes a mixture that your liver may not be working properly.
Load more

Recommended publications
  • Colitis Caused by Non-Steroidal Anti-Inflammatory Drugs
    Postgrad Med J: first published as 10.1136/pgmj.62.730.773 on 1 August 1986. Downloaded from Postgraduate Medical Journal (1986) 62, 773-776 Colitis caused by non-steroidal anti-inflammatory drugs S. Ravi', A.C. Keat2 and E.C.B. Keat1 'Cuckfield Hospital, Cuckfield, West Sussex, and2Westminster Hospital, Horseferry Road, London SWIP2AP, UK. Summary: Four cases of acute proctocolitis associated with non-steroidal anti-inflammatory drug therapy are presented. The drugs implicated were flufenamic acid, mefenamic acid, naproxen and ibuprofen. After resolution of symptoms and signs of proctocolitis three of the four patients were subsequently rechallenged with the implicated drug: in each there was a rapid relapse. Introduction Ulcerative colitis is a disease of unknown aetiology Case reports with characteristic clinical features and a protracted course. A similar clinical picture, but running a shorter Case I and usually benign course, is occasionally seen follow- ing the administration of certain drugs. This was first A 77 year old woman was referred with intermittent noticed following the administration of antibiotics, bleeding per rectum for 6 months, associated for the often with pseudomembrane formation. Later, this last 2 months with bloody diarrhoea up to eight times was shown to be associated with infection by toxigenic daily. Previously, she had had troublesome symptoms Clostridium difficile. Until 1978, most cases were from osteoarthritis of her back and knees for which copyright. associated with treatment with clindamycin but since she had been prescribed flufenamic acid 200 mg thrice that time nearly all antibiotics have been implicated. daily. Her general health had remained good but she Other drugs capable of causing proctocolitis, though appeared pale and her haemoglobin was reduced to by different mechanisms, include phenindione (Keat & 8 g/dl.
    [Show full text]
  • IBUPROFEN Ibuprofen Film-Coated Tablet 200 Mg
    NEW ZEALAND CONSUMER MEDICINE INFORMATION IBUPROFEN Ibuprofen film-coated tablet 200 mg IBUPROFEN also relieves fever • asthma, wheezing or What is in this leaflet (high temperature). shortness of breath • swelling of the face, lips, Please read this leaflet carefully Although IBUPROFEN can relieve tongue which may cause before you start IBUPROFEN. the symptoms of pain and difficulty in swallowing or inflammation, it will not cure your breathing This leaflet answers some common condition. • hives, itching or skin rash. questions about IBUPROFEN. • stomach ache, fever, chills, IBUPROFEN contains the active nausea and vomiting It does not contain all the available ingredient ibuprofen. Ibuprofen • fainting information. It does not take the belongs to a group of medicines place of talking to your doctor or called non-steroidal anti- If you are allergic to aspirin or pharmacist. inflammatory drugs (or NSAIDs). NSAID medicines and take IBUPROFEN, these symptoms All medicines have risks and Your doctor may have prescribed may be severe. benefits. Your doctor has weighed this medicine for another reason. the risks of you taking IBUPROFEN Do not take IBUPROFEN if you against the benefits they expect it Ask your doctor if you have any are in your third trimester of will have for you. questions about why this pregnancy. medicine has been prescribed for It may affect your developing baby if If you have any concerns about you. you take it during this time. taking this medicine, ask your doctor or pharmacist. Many medicines used to treat Do not take IBUPROFEN if you headache, period pain and other have (or have previously) Keep this leaflet with the aches and pains contain aspirin or vomited blood or material that medicine.
    [Show full text]
  • Colonoscopy Instructions
    Colonoscopy Checklist Five days before your colonoscopy: Stop any medications that thin the blood (see list below) Discuss the discontinuation of these medications with your primary care physician to ensure that it is safe to stop them Three days before your colonoscopy: Stop eating high fiber foods including nuts, corn, popcorn, raw fruits, vegetables, and bran Stop fiber supplements The day before your colonoscopy: Have a normal breakfast If your colonoscopy is scheduled before noon the following day, do not have any lunch If your colonoscopy is scheduled after noon, have a light lunch Have clear liquids for the rest of the day (see below) Start prep as instructed by your physician Do not have anything to eat or drink after midnight The day of your colonoscopy: Take your blood pressure medications with a sip of water Make sure you bring your driver’s license or photo ID and leave valuables and jewelry at home Clear Liquid Diet Water Any kind of soft drink (ginger ale, cola, tonic, etc) Gatorade Apple Juice Orange Juice without pulp Lemonade Tea/Coffee (without milk) Dietary supplements (Ensure, Boost, Enlive, etc) Clear broth (vegetable, chicken, or beef) Jell‐O (stay away from red, blue, or purple colors) Ice pops without milk or fruit bits Honey or sugar NO DAIRY PRODUCTS Medications to stop prior to colonoscopy Below is a list of many medications (but not all) that fall into these categories. It is important to remember that there are hundreds of over‐the‐counter medications that contain NSAIDs or aspirin, so it is important to carefully read the label of any medication that you are taking (prescription or over‐the‐counter).
    [Show full text]
  • (Ketorolac Tromethamine Tablets) Rx Only WARNING TORADOL
    TORADOL ORAL (ketorolac tromethamine tablets) Rx only WARNING TORADOLORAL (ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults), management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following IV or IM dosing of ketorolac tromethamine, if necessary. The total combined duration of use of TORADOLORAL and ketorolac tromethamine should not exceed 5 days. TORADOLORAL is not indicated for use in pediatric patients and it is NOT indicated for minor or chronic painful conditions. Increasing the dose of TORADOLORAL beyond a daily maximum of 40 mg in adults will not provide better efficacy but will increase the risk of developing serious adverse events. GASTROINTESTINAL RISK Ketorolac tromethamine, including TORADOL can cause peptic ulcers, gastrointestinal bleeding and/or perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Therefore, TORADOL is CONTRAINDICATED in patients with active peptic ulcer disease, in patients with recent gastrointestinal bleeding or perforation, and in patients with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly patients are at greater risk for serious gastrointestinal events (see WARNINGS). CARDIOVASCULAR RISK NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk (see WARNINGS and CLINICAL STUDIES). TORADOL is CONTRAINDICATED for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS).
    [Show full text]
  • Be Aware of Some Medications
    Aspirin, Pain Relievers, Cold and Fever Remedies and Arthritis Medications when you have asthma, rhinitis or nasal polyps For some people with asthma, rhinitis and nasal polyps, medications such as acetylsalicylic acid or ASA and some arthritis medications can trigger very severe asthma, rhinitis, hives, swelling and shock. If you react to one of these medications, you will probably react to all of the others as well. There are many medications and products that contain ASA. This handout names some. Since new products are coming out all of the time, it is best to check with the pharmacist before using. Check the label yourself as well. If you react to these medications you must: Avoid these medications and products at all times. Let your doctor know right away if you have taken one of the medications and develop symptoms. Check the ingredients on the label yourself. Ask your pharmacist, doctor or other health care provider if you have questions. Get a medical alert bracelet or card that says you are allergic to ASA. Tell all of your health care providers that you are allergic to ASA. For pain control, use acetaminophen. Some products with acetaminophen are Atasol, Tempra, Tylenol and Novo-Gesic. Most people allergic to ASA can use acetaminophen. Firestone Institute for Respiratory Health St. Joseph’s Hospital McMaster University Health Sciences Some Products that Contain ASA 217s, 217s Strong D P 222s Doan’s Backache Pills Pepto-Bismol 282s, 282s Meps Dodd’s Tablets – All Percodan 292s Dolomine 37 Phenaphen with Codeine 692s Dristan Extra Strength PMS-Sulfasalazine A Dristan – All kinds AC&C R AC&C Extra Strength E Ratio-Oxycodan Acetylsalicylic Acid EC ASA Relief ASA Achrocidin Ecotrin – All kinds Robaxisal – All kinds Aggrenox Endodan Alka Seltzer – All kinds Enteric coated ASA S Anacin – All kinds Enteric coated aspirin Salazopyrin Antidol Entrophen – All kinds Salazopyrin Enema Apo-ASA Excedrin Salofalk Enema Apo-Asen Sulfasalazine Arco Pain Tablet F Arthrisin Fiorinal T Artria SR Fiorinal with Codeine Tri-Buffered ASA ASA, A.S.A.
    [Show full text]
  • Efficacy of Ketoprofen Vs. Ibuprofen and Diclofenac: a Systematic Review of the Literature and Meta-Analysis P
    Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis P. Sarzi-Puttini1, F. Atzeni1, L. Lanata2, M. Bagnasco2 1Rheumatology Unit, L. Sacco University Hospital, Milan, Italy; 2Medical Department, Dompé SpA, Milan, Italy. Abstract Objective The aim of this systematic review of the literature and meta-analysis of randomised controlled trials (RCTs) was to compare the efficacy of orally administered ketoprofen with that of ibuprofen and/or diclofenac. Methods The literature was systematically reviewed in accordance with the Cochrane Collaboration guidelines. The search was restricted to randomised clinical trials published in the Medline and Embase databases up to June 2011, and comparing the efficacy of oral ketoprofen (50–200 mg/day) with ibuprofen (600-1800 mg/day) or diclofenac (75–150 mg/day). Results A total of 13 RCTs involving 898 patients met the inclusion criteria: eight comparing ketoprofen with ibuprofen, and five comparing ketoprofen with diclofenac. The results of the meta-analysis showed a statistically significant difference in efficacy in favour of ketoprofen. The difference between ketoprofen and the pooled ibuprofen/diclofenac data was also statistically significant (0.459, 95% CI 0.33-0.58; p=0.00) at all point-estimates of the mean weighted size effect. Ketoprofen was significantly superior to both diclofenac (mean = 0.422; 95% CI 0.19-0.65; p=0.0007) and ibuprofen (mean = 0.475; 95% CI 0.32-0.62; p=0.0000) at all point-estimates. Heterogeneity for the analysed efficacy outcome was not statisically significant in any of the meta-analyses. Conclusion The efficacy of orally administered ketoprofen in relieving moderate-severe pain and improving functional status and general condition was significantly better than that of ibuprofen and/or diclofenac.
    [Show full text]
  • Of 20 PRODUCT MONOGRAPH FLURBIPROFEN Flurbiprofen Tablets BP 50 Mg and 100 Mg Anti-Inflammatory, Analgesic Agent AA PHARM
    PRODUCT MONOGRAPH FLURBIPROFEN Flurbiprofen Tablets BP 50 mg and 100 mg Anti-inflammatory, analgesic agent AA PHARMA INC. DATE OF PREPARATION: 1165 Creditstone Road, Unit #1 April 16, 1991 Vaughan, Ontario L4K 4N7 DATE OF REVISION: February 7, 2019 Submission Control No. 223098 Page 1 of 20 PRODUCT MONOGRAPH NAME OF DRUG FLURBIPROFEN Flurbiprofen Tablets BP 50 mg and 100 mg PHARMACOLOGICAL CLASSIFICATION Anti-inflammatory, analgesic agent ACTIONS AND CLINICAL PHARMACOLOGY FLURBIPROFEN (flurbiprofen), a phenylalkanoic acid derivative, is a non-steroidal anti- inflammatory agent which also possesses analgesic and antipyretic activities. Its mode of action, like that of other non-steroidal anti-inflammatory agents, is not known. However, its therapeutic action is not due to pituitary adrenal stimulation. Flurbiprofen is an inhibitor of prostaglandin synthesis. The resulting decrease in prostaglandin synthesis may partially explain the drug's anti-inflammatory effect at the cellular level. Pharmacokinetics: Flurbiprofen is well absorbed after oral administration, reaching peak blood levels in approximately 1.5 hours (range 0.5 to 4 hours). Administration of flurbiprofen with food does not alter total drug availability but delays absorption. Excretion of flurbiprofen is virtually complete 24 hours after the last dose. The elimination half-life is 5.7 hours with 90% of the half-life values from 3-9 hours. There is no evidence of drug accumulation and flurbiprofen does not induce enzymes that alter its metabolism. Flurbiprofen is rapidly metabolized and excreted in the urine as free and unaltered intact drug (20-25%) and hydroxylated metabolites (60-80%). In animal models of inflammation the metabolites showed no activity.
    [Show full text]
  • A COMPARATIVE STUDY of FLURBIPROFEN and ASPIRIN in SOFT TISSUE TRAUMA Accident Service, Radcliffe Infirmary, Oxford Surgeon
    Br J Sports Med: first published as 10.1136/bjsm.10.1.11 on 1 March 1976. Downloaded from 11 A COMPARATIVE STUDY OF FLURBIPROFEN AND ASPIRIN IN SOFT TISSUE TRAUMA David S. MUCKLE, M.B., B.S., F.R.C.S., M.S. Accident Service, Radcliffe Infirmary, Oxford Surgeon and Medical Adviser to Oxford United F. C. ABSTRACT A double blind study using flurbiprofen (2-(2-fluoro-4-biphenylyl propionic acid) 150 mg daily and soluble aspirin (3.6 g daily) for 5 days immediately after injury, was carried out in 52 soft tissue injuries to the lower limb in professional sportsmen. Flurbiprofen was more effective than aspirin in producing analgesia (when daily pain scores were considered) after day 2 (p < 0.02); and flurbiprofen produced a more effective resolution of soft tissue trauma when days to training and match play were considered (p < 0.05). The inhibitory effects of flurbiprofen on prostaglandin biosynthesis and tissue action are mentioned and the use of anti-inflammatory agents given immediately after soft tissue injuries discussed. Introduction level of pain (mild, moderate or severe) according to instructions outlined on the jacket of the pack, and the In a previous double blind study using a phenylal- appropriate square was marked. The injured area was kanoic acid, "Brufen", (ibuprofen (2-(4-iso-butylphenyl) observed daily by the trainer or club doctor and all signs propionic acid) 1,200 mg daily) and soluble aspirin (3.0 recorded. The dates to full training and match fitness g daily) it was shown that the immediate use of these were noted.
    [Show full text]
  • Topical Pharmaceutical Compositions of Flurbiprofen and Methyl Salicylate
    (19) & (11) EP 2 455 074 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 23.05.2012 Bulletin 2012/21 A61K 31/05 (2006.01) A61K 47/10 (2006.01) A61K 9/00 (2006.01) (21) Application number: 11187973.0 (22) Date of filing: 04.11.2011 (84) Designated Contracting States: • Türkyilmaz, Ali AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 34398 Istanbul (TR) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • Akalin, Nur Pehlivan PL PT RO RS SE SI SK SM TR 34398 Istanbul (TR) Designated Extension States: • Önder, Ramazan BA ME 34398 Istanbul (TR) • Öner, Levent (30) Priority: 08.11.2010 TR 201009220 Ankara (TR) (71) Applicant: Sanovel Ilac Sanayi ve Ticaret A.S. (74) Representative: Sevinç, Erkan 34398 Istanbul (TR) Istanbul Patent & Trademark Consultancy Ltd. Plaza-33, Büyükdere cad. No: 33/16, Sisli (72) Inventors: 34381 Istanbul (TR) • Cifter, Ümit 34398 Istanbul (TR) (54) Topical pharmaceutical compositions of flurbiprofen and methyl salicylate (57) The present invention relates to topical pharma- thermore, the invention relates to process for preparing ceutical compositions comprising flurbiprofen or a phar- the said topical pharmaceutical compositions and its use maceutically acceptable salt thereof and methyl sali- for the treatment of pain and inflammatory symptoms as- cylate. More specifically, the invention relates to topical sociated with muscle-skeletol system, joint and soft-tis- pharmaceutical compositions of flurbiprofen and methyl sue disorders. salicylate characterized in that said composition compris- es dimethyl sulfoxide and one or more gelling agent.
    [Show full text]
  • The Aryl Propionic Acid R-Flurbiprofen Selectively Induces P75ntr- Dependent Decreased Survival of Prostate Tumor Cells Emily J
    Research Article The Aryl Propionic Acid R-Flurbiprofen Selectively Induces p75NTR- Dependent Decreased Survival of Prostate Tumor Cells Emily J. Quann,1 Fatima Khwaja,1 Kenton H. Zavitz,3 and Daniel Djakiew1,2 1Department of Biochemistry and Molecular & Cellular Biology and the 2Vincent T. Lombardi Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, and 3Myriad Pharmaceuticals Inc., Salt Lake City, Utah Abstract oxygenase (COX), the enzyme which catalyzes the conversion of Epidemiologic studies show that patients chronically consum- arachidonic acid to prostaglandins. Two isoforms of COX exist; ing nonsteroidal anti-inflammatory drugs (NSAID) for arthri- COX-1 is a housekeeping gene that is constitutively expressed at tis exhibit a reduced incidence of prostate cancer. In addition, low levels in most cells types, whereas COX-2 is highly inducible in some NSAIDs show anticancer activity in vitro.NSAIDs response to cytokines, hormones, and growth factors. COX-2 seems exert their anti-inflammatory effects by inhibiting cyclo- to play a significant role in the promotion of colon cancer with 50% oxygenase (COX) activity; however,evidence suggests that of precancerous adenomatous polyps and 85% of colon carcinomas COX-independent mechanisms mediate decreased prostate exhibiting COX-2 overexpression (9). However, the data pertaining cancer cell survival. Hence,we examined the effect of selected to the role of COX-2 in prostate cancer are less conclusive. Although some studies show overexpression, others show expres- aryl propionic acid NSAIDs and structurally related com- pounds on the decreased survival of prostate cancer cell lines sion is low or absent relative to normal tissue (10–14).
    [Show full text]
  • Central Nervous System Toxicity of Mefenamic Acid
    Central Nervous System toxicity of mefenamic acid overdose compared to other NSAIDs: an analysis of cases reported to the United Kingdom National Poisons Information Service. Running header: CNS toxicity of mefenamic acid A Kamour1, S Crichton2, G Cooper3, DJ Lupton4, M Eddleston4,5, JA Vale6, JP Thompson 3, SHL Thomas1,7 1National Poisons Information Service, Newcastle Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Wolfson Unit, Claremont Place, Newcastle upon Tyne, NE2 4HH. 2Department of Primary Care and Public Health, King's College London, Capital House, London, SE1 3QD 3National Poisons Information Service, Cardiff Unit, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX. 4National Poisons Information Service, Edinburgh Unit, Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh EH16 4SA. 5Pharmacology, Toxicology and Therapeutics, University/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK. 6National Poisons Information Service, Birmingham Unit, City Hospital, Dudley Road, Birmingham B18 7QH. 7Medical Toxicology Centre, Institute of Cellular Medicine, Wolfson Building, Newcastle University, Newcastle NE2 4HH. Address for correspondence: Dr Ashraf Kamour, Acute Medical Unit, North Manchester General Hospital Delaunays Road, Crumpsall, Manchester, M8 5RB, UK. Tel: +44 (0)161 918 4673 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/bcp.13169 This article is protected by copyright. All rights reserved. Fax: +44 (0)161 604 5323 Email: [email protected] Keywords: Mefenamic acid, non-steroidal anti-inflammatory drug, overdose, poisoning, CNS toxicity, convulsions.
    [Show full text]
  • PATIENT FACT SHEET (Nonsteroidal Anti-Inflammatory Drugs)
    NSAIDs PATIENT FACT SHEET (Nonsteroidal anti-inflammatory drugs) NSAIDs (Nonsteroidal anti-inflammatory drugs) are play a role in pain and inflammation. NSAIDs also can some of the most commonly used pain medicines decrease inflammation, such as fever, swelling and in adults. They are also a common treatment for redness. Traditional NSAIDs include aspirin, ibuprofen chronic (long-term) health problems, such as arthritis (Advil, Motrin, etc.), naproxen (e.g., Aleve) and many (rheumatoid arthritis, osteoarthritis and others) and other generic and brand name drugs. Celecoxib lupus. NSAIDs block proteins, called enzymes, in the (Celebrex) belongs to a newer class of NSAIDs, which WHAT IS IT? body that help make prostaglandins. Prostaglandins doctors call a “COX-2 inhibitor,” and is designed to are a group of naturally occurring fatty acids that avoid upset stomach. Each NSAID has its own dose (strength) and interval improvement of swelling. Do not mix an over-the-counter for how often to take the drug. The dosage size of NSAID with a prescribed NSAID or take more than the over-the-counter medicine (those sold without a doctor’s recommended dose of the NSAID. Doing so could increase prescription) is often less than prescription versions of the your chance of side effects. Doctors have long warned not same medicine. NSAIDs start to work quickly, most often to give aspirin to children under age 12, but teens with a within a few hours. How fast they take affect depends virus also should avoid drugs containing aspirin. There is a HOW TO on the intended effect. Pain control tends to occur risk of Reye’s syndrome, a rare but deadly illness that can TAKE IT much quicker than anti-inflammatory effects, such as affect the brain and liver.
    [Show full text]